Clinical Trials

Showing trials with last updates posted in 2025.

NCT04541082 | RECRUITING | PHASE1
102 participants

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-18
Start Date:
2020-10-26
Completion:
2026-07-31
Conditions
  • Central Nervous System Neoplasms
  • Glioblastoma
  • Gliosarcoma, Adult
  • Anaplastic Oligodendroglioma
  • Anaplastic Astrocytoma
  • Pilocytic Astrocytoma
  • Oligodendroglioma
  • Gliomatosis Cerebri
  • Pleomorphic Xanthoastrocytoma
  • Anaplastic Pleomorphic Xanthoastrocytoma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Ependymoma
  • Ependymoma, Anaplastic
  • Medulloblastoma
  • Teratoid Rhabdoid Tumor
  • Neuroectodermal Tumors, Primitive
  • Neuroectodermal Tumors
  • Anaplastic Meningioma
  • Atypical Meningioma
  • Choroid Plexus Neoplasms
  • Pineal Tumor
  • Diffuse Astrocytoma
  • Glial Tumor
Interventions
  • DRUG
No Results Yet
NCT04395495 | RECRUITING
1000 participants

RASopathy Biorepository

Study Type:
OBSERVATIONAL
Last Updated:
2025-12-18
Start Date:
2017-06-27
Completion:
2065-12-31
Conditions
  • RAS Mutation
  • Neurofibromatosis 1
  • Noonan Syndrome
  • Noonan Syndrome With Multiple Lentigines
  • Noonan Neurofibromatosis Syndrome
  • Cardiofaciocutaneous Syndrome
  • Costello Syndrome
  • Legius Syndrome
  • Smith-Kingsmore Syndrome
  • MTOR Gene Mutation
  • GATOR-1 Gene Mutation
  • SYNGAP1-Related Intellectual Disability
  • DLG4
  • MAPK1 Gene Mutation
No Results Yet
NCT04100148 | ACTIVE_NOT_RECRUITING | NA
1686 participants

SyncAV Post-Market Trial

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-18
Start Date:
2019-10-03
Completion:
2026-05-31
Conditions
  • Congestive Heart Failure
Interventions
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page